Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
19–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Females must be of nonchildbearing potential or of childbearing potential and agree to use contraception
Males must either be infertile via bilateral orchiectomy or vasectomized at least 90 days prior to screening with proper documentation
Body mass index (BMI) between 18.5 and 32.0 kilogram per square meter (kg/m²)
In good general health, determined by no clinically significant findings from medical history, physical examination, 12 lead electrocardiogram (ECGs), vital signs measurements, or clinical laboratory evaluations at screening and/or check-in as assessed by the investigator (or designee)
You may not be if
Females only: Are lactating or pregnant
Any history or presence of disease(s), deemed clinically significant:
* Dermatological disease
* Liver disease
* Metabolic disease, including congenital nonhemolytic hyperbilirubinemia (e.g., Gilbert syndrome)
* Gastrointestinal disease, including peptic ulcer disease, active malabsorption syndrome or other condition likely to affect gastrointestinal absorption of the study drug, or gastric reduction surgery. Note: participants with a history of appendectomy and/or inguinal hernia repairs will be acceptable
* Biliary disease, including cholecystectomy
* Cancer within the past 5 years (except localized basal cell, squamous, or in situ cancer of the skin)
* History or current evidence of ophthalmic disorder, such as central serous retinopathy or retinal vein occlusion, active wet age-related macular degeneration, diabetic retinopathy with macular edema, uncontrolled glaucoma, corneal pathology such as keratitis, keratoconjunctivitis, keratopathy, corneal abrasion, inflammation or ulceration
* Clinically significant, active cardiovascular disease or history of myocardial infarction within 6 months prior to first dose, or 12-lead ECG abnormalities that are clinically significant at screening
History of alcohol and/or drug abuse within 2 years prior to screening
Have been on a diet incompatible with the on-study diet, in the opinion of the investigator (or designee), and as confirmed by the sponsor, within the 30 days prior to Day 1 and throughout
Use of tobacco, smoking cessation products, products containing nicotine, or e-cigarettes (nicotine and non-nicotine) within 90 days prior to screening and throughout
Clareo Health | A Study of LY3866288 in Healthy Participants
